Impact of dose feasibility on the conduct of phase I trials of adoptive cell therapy by Evan M. Bagley, Nolan A. Wages

Get full text

A web tool for designing and conducting phase I trials using the continual reassessment method by Nolan A. Wages, Gina R. Petroni

Get full text

Exclusion of local actors from coordination leadership in child protection by Maina, U, Machuor, D, Nolan, A

Relationship of dose to vascular target volumes and local failure in pancreatic cancer patients undergoing neoadjuvant chemoradiation by Bailey Nelson, Michelle Barrord, Kyle Wang, Nolan A. Wages, Nolan A. Wages, Mickaela Sudhoff, Jordan Kharofa

Get full text

Design considerations for early-phase clinical trials of immune-oncology agents by Nolan A. Wages, Cody Chiuzan, Katherine S. Panageas

Get full text

Concurrent dose-finding of a novel cancer drug with and without a second agent by Nolan A. Wages, Ramy R. Saleh, Thomas M. Braun

Get full text

Obtaining the Optimal Dose in Alcohol Dependence Studies by Nolan A. Wages, Lei eLiu, John eO'Quigley, Bankole eJohnson

Get full text

Predator‐specific mortality of sage‐grouse nests based on predator DNA on eggshells by Nolan A. Helmstetter, Courtney J. Conway, Shane Roberts, Jennifer R. Adams, Paul D. Makela, Lisette P. Waits

Get full text

A Pilot Study of the Combination of Entinostat with Capecitabine in Advanced Breast Cancer by Trish Millard, Christiana Brenin, Clare Humphrey, Ajay Dhakal, Carla Falkson, Gina Petroni, Nolan A. Wages, Patrick Dillon

Get full text

Collaborative Learning Communities With Medical Students as Teachers by Chenyi Yang, Konnor Davis, Michael Head, Nolan A. Huck, Tyler Irani, Andrew Ovakimyan, Aaron Frank, Andrew Cuyegkeng, Lauren Stokes

Get full text

Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma by Ileana S Mauldin, Nolan A Wages, Max O Meneveau, Kevin T Lynch, Samuel J Young, Craig L Slingluff Jr, Victor H Engelhard

Get full text

External Validation of Deep Learning Models for Classifying Etiology of Retinal Hemorrhage Using Diverse Fundus Photography Datasets by Pooya Khosravi, Nolan A. Huck, Kourosh Shahraki, Elina Ghafari, Reza Azimi, So Young Kim, Eric Crouch, Xiaohui Xie, Donny W. Suh

Get full text

Proliferating CD8⁺ T Cell Infiltrates Are Associated with Improved Survival in Glioblastoma by Ileana S. Mauldin, Jasmin Jo, Nolan A. Wages, Lalanthica V. Yogendran, Adela Mahmutovic, Samuel J. Young, Maria Beatriz Lopes, Craig L. Slingluff, Loren D. Erickson, Camilo E. Fadul

Get full text

Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund’s adjuvant, cyclophosphamide, and polyICLC (Mel63) by Kelly T Smith, Nikole Varhegyi, Nolan A Wages, Emily H Hall, Kathleen Haden, Craig L Slingluff, Jr., Lynn T Dengel, Anna Dickinson, Caroline Reed, Elizabeth M Gaughan, Varinder Kaur, Nadejda V Galeassi

Get full text

Formation and phenotypic characterization of CD49a, CD49b and CD103 expressing CD8 T cell populations in human metastatic melanoma by Marit M. Melssen, Walter Olson, Nolan A. Wages, Brian J. Capaldo, Ileana S. Mauldin, Adela Mahmutovic, Ciara Hutchison, Cornelis J.M. Melief, Timothy N. Bullock, Victor H. Engelhard, Craig L. Slingluff

Get full text

Venetoclax with decitabine or azacitidine in the first‐line treatment of acute myeloid leukemia by Ian M. Bouligny, Graeme Murray, Michael Doyel, Tilak Patel, Josh Boron, Valerie Tran, Juhi Gor, Yiwei Hang, Yanal Alnimer, Kyle Zacholski, Chad Venn, Nolan A. Wages, Steven Grant, Keri R. Maher

Get full text

Genetic association analysis reveals differences in the contribution of NOD2 variants to the clinical phenotypes of orofacial granulomatosis by Mentzer, A, Nayee, S, Omar, Y, Hullah, E, Taylor, K, Goel, R, Bye, H, Shembesh, T, Elliott, T, Campbell, H, Patel, P, Nolan, A, Mansfield, J, Challacombe, S, Escudier, M, Mathew, C, Sanderson, J, Prescott, N

Sex-distinct microglial activation and myeloid cell infiltration in the spinal cord after painful peripheral injury by Nolan A. Huck, Lauren J. Donovan, Huaishuang Shen, Claire E. Jordan, Gabriella P.B. Muwanga, Caldwell M. Bridges, Thomas E. Forman, Stephanie A. Cordonnier, Elena S. Haight, Fiona Dale-Huang, Yoshinori Takemura, Vivianne L. Tawfik

Get full text

Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund’s adjuvant (IFA) for resected high-risk melanoma by Patrick Hwu, Jason Roszik, Gina R Petroni, Walter C Olson, Kimberly A Chianese-bullock, Kelly T Smith, Nikole Varhegyi, Elizabeth Gaughan, Mark Smolkin, Sacha Gnjatic, Nolan A Wages, Emily H Hall, Kathleen Haden, Sapna P Patel

Get full text

A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund’s adjuvant in melanoma patients by Marit M. Melssen, Gina R. Petroni, Kimberly A. Chianese-Bullock, Nolan A. Wages, William W. Grosh, Nikole Varhegyi, Mark E. Smolkin, Kelly T. Smith, Nadejda V. Galeassi, Donna H. Deacon, Elizabeth M. Gaughan, Craig L. Slingluff

Get full text